APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amplicon Sequencing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Amplicon Sequencing Market Outlook and Growth Opportunities 2026

4 March 2026213 pages

Choose your research edition.

Industry ResearchAmplicon Sequencing Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Amplicon Sequencing Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Amplicon Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amplicon Sequencing Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Amplicon Sequencing Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Amplicon Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Amplicon Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Amplicon Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amplicon Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Amplicon Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Amplicon Sequencing market include IDT, Azenta Life Sciences, Eurofins Genomics, Novogene, BGI (BGI Genomics), Macrogen, Psomagen, SeqMatic and CD Genomics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Amplicon Sequencing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Amplicon Sequencing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amplicon Sequencing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Amplicon Sequencing market.

Amplicon Sequencing Segment by Company

IDT

Azenta Life Sciences

Eurofins Genomics

Novogene

BGI (BGI Genomics)

Macrogen

Psomagen

SeqMatic

CD Genomics

AllGenetics

Charles River

Source BioScience

AGRF

Plasmidsaurus

Eurofins Scientific

Charles River Laboratories

ABM

Zymo Research

Paragon Genomics

Quintara Bio

HyLabs

MUGTC

SeqCoast Genomics

Shanghai Baiqu Biomedical Technology

Illumina

Guangzhou IGE Biotechnology

Amplicon Sequencing Segment by Type

16S rDNA Sequencing

ITS Sequencing

Target Region Amplicon Sequencing

Others

Amplicon Sequencing Segment by Application

Human Health and Clinical Research

Agriculture and Food Safety

Pharmaceutical and Biotechnology Research

Forensics and Population Genetics

Others

Amplicon Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Amplicon Sequencing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Amplicon Sequencing key companies, revenue, market share, and recent developments.

3. To split the Amplicon Sequencing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Amplicon Sequencing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Amplicon Sequencing significant trends, drivers, influence factors in global and regions.

6. To analyze Amplicon Sequencing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amplicon Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amplicon Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amplicon Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Amplicon Sequencing industry.

Chapter 3: Detailed analysis of Amplicon Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Amplicon Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Amplicon Sequencing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Amplicon Sequencing Industry Trends Table 2. Amplicon Sequencing Industry Drivers Table 3. Amplicon Sequencing Industry Opportunities and Challenges Table 4. Amplicon Sequencing Industry Restraints Table 5. Global Amplicon Sequencing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Amplicon Sequencing Revenue Share by Company (2021-2026) Table 7. Global Amplicon Sequencing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Amplicon Sequencing Key Company Manufacturing Base & Headquarters Table 9. Global Amplicon Sequencing Company, Product Type & Application Table 10. Global Amplicon Sequencing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Amplicon Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 16S rDNA Sequencing Table 15. Significant Companies of ITS Sequencing Table 16. Significant Companies of Target Region Amplicon Sequencing Table 17. Significant Companies of Others Table 18. Global Amplicon Sequencing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Amplicon Sequencing Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Amplicon Sequencing Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Amplicon Sequencing Sales Value Share by Type (2021-2026) Table 22. Global Amplicon Sequencing Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Human Health and Clinical Research Table 24. Significant Companies of Agriculture and Food Safety Table 25. Significant Companies of Pharmaceutical and Biotechnology Research Table 26. Significant Companies of Forensics and Population Genetics Table 27. Significant Companies of Others Table 28. Global Amplicon Sequencing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Amplicon Sequencing Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Amplicon Sequencing Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Amplicon Sequencing Sales Value Share by Application (2021-2026) Table 32. Global Amplicon Sequencing Sales Value Share by Application (2027-2032) Table 33. Global Amplicon Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Amplicon Sequencing Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Amplicon Sequencing Sales Value Share by Region (2021-2026) Table 36. Global Amplicon Sequencing Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Amplicon Sequencing Sales Value Share by Region (2027-2032) Table 38. Global Amplicon Sequencing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Amplicon Sequencing Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Amplicon Sequencing Sales Value Market Share by Country (2021-2026) Table 41. Global Amplicon Sequencing Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Amplicon Sequencing Sales Value Market Share by Country (2027-2032) Table 43. IDT Company Information Table 44. IDT Business Overview Table 45. IDT Amplicon Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. IDT Amplicon Sequencing Product Portfolio Table 47. IDT Recent Development Table 48. Azenta Life Sciences Company Information Table 49. Azenta Life Sciences Business Overview Table 50. Azenta Life Sciences Amplicon Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Azenta Life Sciences Amplicon Sequencing Product Portfolio Table 52. Azenta Life Sciences Recent Development Table 53. Eurofins Genomics Company Information Table 54. Eurofins Genomics Business Overview Table 55. Eurofins Genomics Amplicon Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Eurofins Genomics Amplicon Sequencing Product Portfolio Table 57. Eurofins Genomics Recent Development Table 58. Novogene Company Information Table 59. Novogene Business Overview Table 60. Novogene Amplicon Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Novogene Amplicon Sequencing Product Portfolio Table 62. Novogene Recent Development Table 63. BGI (BGI Genomics) Company Information Table 64. BGI (BGI Genomics) Business Overview Table 65. BGI (BGI Genomics) Amplicon Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. BGI (BGI Genomics) Amplicon Sequencing Product Portfolio Table 67. BGI (BGI Genomics) Recent Development Table 68. Macrogen Company Information Table 69. Macrogen Business Overview Table 70. Macrogen Amplicon Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Macrogen Amplicon Sequencing Product Portfolio Table 72. Macrogen Recent Development Table 73. Psomagen Company Information Table 74. Psomagen Business Overview Table 75. Psomagen Amplicon Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Psomagen Amplicon Sequencing Product Portfolio Table 77. Psomagen Recent Development Table 78. SeqMatic Company Information Table 79. SeqMatic Business Overview Table 80. SeqMatic Amplicon Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. SeqMatic Amplicon Sequencing Product Portfolio Table 82. SeqMatic Recent Development Table 83. CD Genomics Company Information Table 84. CD Genomics Business Overview Table 85. CD Genomics Amplicon Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. CD Genomics Amplicon Sequencing Product Portfolio Table 87. CD Genomics Recent Development Table 88. AllGenetics Company Information Table 89. AllGenetics Business Overview Table 90. AllGenetics Amplicon Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. AllGenetics Amplicon Sequencing Product Portfolio Table 92. AllGenetics Recent Development Table 93. Charles River Company Information Table 94. Charles River Business Overview Table 95. Charles River Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Charles River Amplicon Sequencing Product Portfolio Table 97. Charles River Recent Development Table 98. Source BioScience Company Information Table 99. Source BioScience Business Overview Table 100. Source BioScience Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Source BioScience Amplicon Sequencing Product Portfolio Table 102. Source BioScience Recent Development Table 103. AGRF Company Information Table 104. AGRF Business Overview Table 105. AGRF Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. AGRF Amplicon Sequencing Product Portfolio Table 107. AGRF Recent Development Table 108. Plasmidsaurus Company Information Table 109. Plasmidsaurus Business Overview Table 110. Plasmidsaurus Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Plasmidsaurus Amplicon Sequencing Product Portfolio Table 112. Plasmidsaurus Recent Development Table 113. Eurofins Scientific Company Information Table 114. Eurofins Scientific Business Overview Table 115. Eurofins Scientific Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Eurofins Scientific Amplicon Sequencing Product Portfolio Table 117. Eurofins Scientific Recent Development Table 118. Charles River Laboratories Company Information Table 119. Charles River Laboratories Business Overview Table 120. Charles River Laboratories Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Charles River Laboratories Amplicon Sequencing Product Portfolio Table 122. Charles River Laboratories Recent Development Table 123. ABM Company Information Table 124. ABM Business Overview Table 125. ABM Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. ABM Amplicon Sequencing Product Portfolio Table 127. ABM Recent Development Table 128. Zymo Research Company Information Table 129. Zymo Research Business Overview Table 130. Zymo Research Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Zymo Research Amplicon Sequencing Product Portfolio Table 132. Zymo Research Recent Development Table 133. Paragon Genomics Company Information Table 134. Paragon Genomics Business Overview Table 135. Paragon Genomics Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Paragon Genomics Amplicon Sequencing Product Portfolio Table 137. Paragon Genomics Recent Development Table 138. Quintara Bio Company Information Table 139. Quintara Bio Business Overview Table 140. Quintara Bio Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Quintara Bio Amplicon Sequencing Product Portfolio Table 142. Quintara Bio Recent Development Table 143. HyLabs Company Information Table 144. HyLabs Business Overview Table 145. HyLabs Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. HyLabs Amplicon Sequencing Product Portfolio Table 147. HyLabs Recent Development Table 148. MUGTC Company Information Table 149. MUGTC Business Overview Table 150. MUGTC Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. MUGTC Amplicon Sequencing Product Portfolio Table 152. MUGTC Recent Development Table 153. SeqCoast Genomics Company Information Table 154. SeqCoast Genomics Business Overview Table 155. SeqCoast Genomics Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. SeqCoast Genomics Amplicon Sequencing Product Portfolio Table 157. SeqCoast Genomics Recent Development Table 158. Shanghai Baiqu Biomedical Technology Company Information Table 159. Shanghai Baiqu Biomedical Technology Business Overview Table 160. Shanghai Baiqu Biomedical Technology Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. Shanghai Baiqu Biomedical Technology Amplicon Sequencing Product Portfolio Table 162. Shanghai Baiqu Biomedical Technology Recent Development Table 163. Illumina Company Information Table 164. Illumina Business Overview Table 165. Illumina Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. Illumina Amplicon Sequencing Product Portfolio Table 167. Illumina Recent Development Table 168. Guangzhou IGE Biotechnology Company Information Table 169. Guangzhou IGE Biotechnology Business Overview Table 170. Guangzhou IGE Biotechnology Amplicon Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 171. Guangzhou IGE Biotechnology Amplicon Sequencing Product Portfolio Table 172. Guangzhou IGE Biotechnology Recent Development Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Amplicon Sequencing Product Image Figure 2. Global Amplicon Sequencing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amplicon Sequencing Market Size (2021-2032) & (US$ Million) Figure 4. Global Amplicon Sequencing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 16S rDNA Sequencing Image Figure 8. ITS Sequencing Image Figure 9. Target Region Amplicon Sequencing Image Figure 10. Others Image Figure 11. Global Amplicon Sequencing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Amplicon Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Amplicon Sequencing Sales Value Share by Type (2021-2032) Figure 14. Human Health and Clinical Research Image Figure 15. Agriculture and Food Safety Image Figure 16. Pharmaceutical and Biotechnology Research Image Figure 17. Forensics and Population Genetics Image Figure 18. Others Image Figure 19. Global Amplicon Sequencing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Amplicon Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Amplicon Sequencing Sales Value Share by Application (2021-2032) Figure 22. Global Amplicon Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Amplicon Sequencing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Amplicon Sequencing Sales Value (2021-2032) & (US$ Million) Figure 25. North America Amplicon Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Amplicon Sequencing Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Amplicon Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Amplicon Sequencing Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Amplicon Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Amplicon Sequencing Sales Value (2021-2032) & (US$ Million) Figure 31. South America Amplicon Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Amplicon Sequencing Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Amplicon Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Amplicon Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • 16S rDNA Sequencing
  • ITS Sequencing
  • Target Region Amplicon Sequencing
  • Others
Applications
  • Human Health and Clinical Research
  • Agriculture and Food Safety
  • Pharmaceutical and Biotechnology Research
  • Forensics and Population Genetics
  • Others
Companies covered
  • IDT
  • Azenta Life Sciences
  • Eurofins Genomics
  • Novogene
  • BGI (BGI Genomics)
  • Macrogen
  • Psomagen
  • SeqMatic
  • CD Genomics
  • AllGenetics
  • Charles River
  • Source BioScience
  • AGRF
  • Plasmidsaurus
  • Eurofins Scientific
  • Charles River Laboratories
  • ABM
  • Zymo Research
  • Paragon Genomics
  • Quintara Bio
  • HyLabs
  • MUGTC
  • SeqCoast Genomics
  • Shanghai Baiqu Biomedical Technology
  • Illumina
  • Guangzhou IGE Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Amplicon Sequencing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Amplicon Sequencing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Amplicon Sequencing Market Dynamics
  1. 2.1 Amplicon Sequencing Industry Trends
  2. 2.2 Amplicon Sequencing Industry Drivers
  3. 2.3 Amplicon Sequencing Industry Opportunities and Challenges
  4. 2.4 Amplicon Sequencing Industry Restraints
3 Amplicon Sequencing Market by Company
  1. 3.1 Global Amplicon Sequencing Company Revenue Ranking in 2025
  2. 3.2 Global Amplicon Sequencing Revenue by Company (2021-2026)
  3. 3.3 Global Amplicon Sequencing Company Ranking (2024-2026)
  4. 3.4 Global Amplicon Sequencing Company Manufacturing Base and Headquarters
  5. 3.5 Global Amplicon Sequencing Company Product Type and Application
  6. 3.6 Global Amplicon Sequencing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Amplicon Sequencing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Amplicon Sequencing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Amplicon Sequencing Market by Type
  1. 4.1 Amplicon Sequencing Type Introduction
  2. 4.1.1 16S rDNA Sequencing
  3. 4.1.2 ITS Sequencing
  4. 4.1.3 Target Region Amplicon Sequencing
  5. 4.1.4 Others
  6. 4.2 Global Amplicon Sequencing Sales Value by Type
  7. 4.2.1 Global Amplicon Sequencing Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Amplicon Sequencing Sales Value by Type (2021-2032)
  9. 4.2.3 Global Amplicon Sequencing Sales Value Share by Type (2021-2032)
5 Amplicon Sequencing Market by Application
  1. 5.1 Amplicon Sequencing Application Introduction
  2. 5.1.1 Human Health and Clinical Research
  3. 5.1.2 Agriculture and Food Safety
  4. 5.1.3 Pharmaceutical and Biotechnology Research
  5. 5.1.4 Forensics and Population Genetics
  6. 5.1.5 Others
  7. 5.2 Global Amplicon Sequencing Sales Value by Application
  8. 5.2.1 Global Amplicon Sequencing Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Amplicon Sequencing Sales Value by Application (2021-2032)
  10. 5.2.3 Global Amplicon Sequencing Sales Value Share by Application (2021-2032)
6 Amplicon Sequencing Regional Value Analysis
  1. 6.1 Global Amplicon Sequencing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Amplicon Sequencing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Amplicon Sequencing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Amplicon Sequencing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Amplicon Sequencing Sales Value (2021-2032)
  7. 6.3.2 North America Amplicon Sequencing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Amplicon Sequencing Sales Value (2021-2032)
  10. 6.4.2 Europe Amplicon Sequencing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Amplicon Sequencing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Amplicon Sequencing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Amplicon Sequencing Sales Value (2021-2032)
  16. 6.6.2 South America Amplicon Sequencing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Amplicon Sequencing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Amplicon Sequencing Sales Value Share by Country, 2025 VS 2032
7 Amplicon Sequencing Country-level Value Analysis
  1. 7.1 Global Amplicon Sequencing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Amplicon Sequencing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Amplicon Sequencing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Amplicon Sequencing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Amplicon Sequencing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Amplicon Sequencing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Amplicon Sequencing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 IDT
  2. 8.1.1 IDT Company Information
  3. 8.1.2 IDT Business Overview
  4. 8.1.3 IDT Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 IDT Amplicon Sequencing Product Portfolio
  6. 8.1.5 IDT Recent Developments
  7. 8.2 Azenta Life Sciences
  8. 8.2.1 Azenta Life Sciences Company Information
  9. 8.2.2 Azenta Life Sciences Business Overview
  10. 8.2.3 Azenta Life Sciences Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Azenta Life Sciences Amplicon Sequencing Product Portfolio
  12. 8.2.5 Azenta Life Sciences Recent Developments
  13. 8.3 Eurofins Genomics
  14. 8.3.1 Eurofins Genomics Company Information
  15. 8.3.2 Eurofins Genomics Business Overview
  16. 8.3.3 Eurofins Genomics Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eurofins Genomics Amplicon Sequencing Product Portfolio
  18. 8.3.5 Eurofins Genomics Recent Developments
  19. 8.4 Novogene
  20. 8.4.1 Novogene Company Information
  21. 8.4.2 Novogene Business Overview
  22. 8.4.3 Novogene Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novogene Amplicon Sequencing Product Portfolio
  24. 8.4.5 Novogene Recent Developments
  25. 8.5 BGI (BGI Genomics)
  26. 8.5.1 BGI (BGI Genomics) Company Information
  27. 8.5.2 BGI (BGI Genomics) Business Overview
  28. 8.5.3 BGI (BGI Genomics) Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BGI (BGI Genomics) Amplicon Sequencing Product Portfolio
  30. 8.5.5 BGI (BGI Genomics) Recent Developments
  31. 8.6 Macrogen
  32. 8.6.1 Macrogen Company Information
  33. 8.6.2 Macrogen Business Overview
  34. 8.6.3 Macrogen Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Macrogen Amplicon Sequencing Product Portfolio
  36. 8.6.5 Macrogen Recent Developments
  37. 8.7 Psomagen
  38. 8.7.1 Psomagen Company Information
  39. 8.7.2 Psomagen Business Overview
  40. 8.7.3 Psomagen Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Psomagen Amplicon Sequencing Product Portfolio
  42. 8.7.5 Psomagen Recent Developments
  43. 8.8 SeqMatic
  44. 8.8.1 SeqMatic Company Information
  45. 8.8.2 SeqMatic Business Overview
  46. 8.8.3 SeqMatic Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SeqMatic Amplicon Sequencing Product Portfolio
  48. 8.8.5 SeqMatic Recent Developments
  49. 8.9 CD Genomics
  50. 8.9.1 CD Genomics Company Information
  51. 8.9.2 CD Genomics Business Overview
  52. 8.9.3 CD Genomics Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CD Genomics Amplicon Sequencing Product Portfolio
  54. 8.9.5 CD Genomics Recent Developments
  55. 8.10 AllGenetics
  56. 8.10.1 AllGenetics Company Information
  57. 8.10.2 AllGenetics Business Overview
  58. 8.10.3 AllGenetics Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AllGenetics Amplicon Sequencing Product Portfolio
  60. 8.10.5 AllGenetics Recent Developments
  61. 8.11 Charles River
  62. 8.11.1 Charles River Company Information
  63. 8.11.2 Charles River Business Overview
  64. 8.11.3 Charles River Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Charles River Amplicon Sequencing Product Portfolio
  66. 8.11.5 Charles River Recent Developments
  67. 8.12 Source BioScience
  68. 8.12.1 Source BioScience Company Information
  69. 8.12.2 Source BioScience Business Overview
  70. 8.12.3 Source BioScience Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Source BioScience Amplicon Sequencing Product Portfolio
  72. 8.12.5 Source BioScience Recent Developments
  73. 8.13 AGRF
  74. 8.13.1 AGRF Company Information
  75. 8.13.2 AGRF Business Overview
  76. 8.13.3 AGRF Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AGRF Amplicon Sequencing Product Portfolio
  78. 8.13.5 AGRF Recent Developments
  79. 8.14 Plasmidsaurus
  80. 8.14.1 Plasmidsaurus Company Information
  81. 8.14.2 Plasmidsaurus Business Overview
  82. 8.14.3 Plasmidsaurus Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Plasmidsaurus Amplicon Sequencing Product Portfolio
  84. 8.14.5 Plasmidsaurus Recent Developments
  85. 8.15 Eurofins Scientific
  86. 8.15.1 Eurofins Scientific Company Information
  87. 8.15.2 Eurofins Scientific Business Overview
  88. 8.15.3 Eurofins Scientific Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Eurofins Scientific Amplicon Sequencing Product Portfolio
  90. 8.15.5 Eurofins Scientific Recent Developments
  91. 8.16 Charles River Laboratories
  92. 8.16.1 Charles River Laboratories Company Information
  93. 8.16.2 Charles River Laboratories Business Overview
  94. 8.16.3 Charles River Laboratories Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Charles River Laboratories Amplicon Sequencing Product Portfolio
  96. 8.16.5 Charles River Laboratories Recent Developments
  97. 8.17 ABM
  98. 8.17.1 ABM Company Information
  99. 8.17.2 ABM Business Overview
  100. 8.17.3 ABM Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 ABM Amplicon Sequencing Product Portfolio
  102. 8.17.5 ABM Recent Developments
  103. 8.18 Zymo Research
  104. 8.18.1 Zymo Research Company Information
  105. 8.18.2 Zymo Research Business Overview
  106. 8.18.3 Zymo Research Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Zymo Research Amplicon Sequencing Product Portfolio
  108. 8.18.5 Zymo Research Recent Developments
  109. 8.19 Paragon Genomics
  110. 8.19.1 Paragon Genomics Company Information
  111. 8.19.2 Paragon Genomics Business Overview
  112. 8.19.3 Paragon Genomics Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Paragon Genomics Amplicon Sequencing Product Portfolio
  114. 8.19.5 Paragon Genomics Recent Developments
  115. 8.20 Quintara Bio
  116. 8.20.1 Quintara Bio Company Information
  117. 8.20.2 Quintara Bio Business Overview
  118. 8.20.3 Quintara Bio Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Quintara Bio Amplicon Sequencing Product Portfolio
  120. 8.20.5 Quintara Bio Recent Developments
  121. 8.21 HyLabs
  122. 8.21.1 HyLabs Company Information
  123. 8.21.2 HyLabs Business Overview
  124. 8.21.3 HyLabs Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  125. 8.21.4 HyLabs Amplicon Sequencing Product Portfolio
  126. 8.21.5 HyLabs Recent Developments
  127. 8.22 MUGTC
  128. 8.22.1 MUGTC Company Information
  129. 8.22.2 MUGTC Business Overview
  130. 8.22.3 MUGTC Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  131. 8.22.4 MUGTC Amplicon Sequencing Product Portfolio
  132. 8.22.5 MUGTC Recent Developments
  133. 8.23 SeqCoast Genomics
  134. 8.23.1 SeqCoast Genomics Company Information
  135. 8.23.2 SeqCoast Genomics Business Overview
  136. 8.23.3 SeqCoast Genomics Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  137. 8.23.4 SeqCoast Genomics Amplicon Sequencing Product Portfolio
  138. 8.23.5 SeqCoast Genomics Recent Developments
  139. 8.24 Shanghai Baiqu Biomedical Technology
  140. 8.24.1 Shanghai Baiqu Biomedical Technology Company Information
  141. 8.24.2 Shanghai Baiqu Biomedical Technology Business Overview
  142. 8.24.3 Shanghai Baiqu Biomedical Technology Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Shanghai Baiqu Biomedical Technology Amplicon Sequencing Product Portfolio
  144. 8.24.5 Shanghai Baiqu Biomedical Technology Recent Developments
  145. 8.25 Illumina
  146. 8.25.1 Illumina Company Information
  147. 8.25.2 Illumina Business Overview
  148. 8.25.3 Illumina Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Illumina Amplicon Sequencing Product Portfolio
  150. 8.25.5 Illumina Recent Developments
  151. 8.26 Guangzhou IGE Biotechnology
  152. 8.26.1 Guangzhou IGE Biotechnology Company Information
  153. 8.26.2 Guangzhou IGE Biotechnology Business Overview
  154. 8.26.3 Guangzhou IGE Biotechnology Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Guangzhou IGE Biotechnology Amplicon Sequencing Product Portfolio
  156. 8.26.5 Guangzhou IGE Biotechnology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst